Edesa Biotech Announces Pricing of $25.0 Million Public Offering
Financial PostAugust 20, 2026
TORONTO, Aug. 19, 2026 (GLOBE NEWSWIRE) — Edesa Biotech, Inc. (Nasdaq: EDSA) (the “Company” or “Edesa”), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today announced the pricing …
Where this sits on TrendsMap
This story hasn’t been tied to a specific state or province yet — it sits in our Canada coverage. We hold 2152 politics stories in total, and 1273 from Financial Post.
This is a summary of reporting by Financial Post. Read the full story at the source.
Read full storyPredictions (0)
No predictions yet on this story — be the first to start one.
Comments (0)
GU
posting as a guest
Create a free account to comment under your own name and earn Pulse.